In fiscal 2026, which ended Mar 31, 2026, STERIS plc reported revenue of $5.9 billion, up 8.7% from the year before. Net income was $782.3 million, a profit margin of 13.2%. Operating income came to $1.1 billion, an operating margin of 18.6%. Diluted earnings per share were $7.93. Over the twelve months ended Jun 30, 2026, revenue was $6.0 billion and net income was $805.0 million. Across the 8 fiscal years shown, revenue grew from $2.8 billion in fiscal 2019 to $5.9 billion in fiscal 2026, about 11.4% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2027
Jun 30, 2026
|
FY 2026
Mar 31, 2026
|
FY 2025
Mar 31, 2025
|
FY 2024
Mar 31, 2024
|
FY 2023
Mar 31, 2023
|
FY 2022
Mar 31, 2022
|
FY 2021
Mar 31, 2021
|
FY 2020
Mar 31, 2020
|
FY 2019
Mar 31, 2019
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
6,038
+8.4%
|
5,936
+8.7%
|
5,460
+6.2%
|
5,139
+13.3%
|
4,536
+7.4%
|
4,223
+35.9%
|
3,108
+2.5%
|
3,031
+8.9%
|
2,782
|
| Cost of revenue |
3,355
+7.8%
|
3,309
+8.3%
|
3,057
+4.7%
|
2,920
+14.3%
|
2,556
+9.2%
|
2,340
+32.6%
|
1,764
+3.1%
|
1,711
+6.5%
|
1,607
|
| Gross profit |
2,683
+9.1%
|
2,626
+9.3%
|
2,403
+8.3%
|
2,218
+12.0%
|
1,981
+5.2%
|
1,883
+40.2%
|
1,343
+1.8%
|
1,320
+12.3%
|
1,175
|
| Research and development |
115
+6.2%
|
113
+4.9%
|
108
+3.8%
|
104
+5.3%
|
98
+13.6%
|
87
+30.7%
|
66
+1.2%
|
66
+4.0%
|
63
|
| Selling, general and administrative |
1,424
+5.3%
|
1,408
+5.5%
|
1,334
+6.5%
|
1,252
+14.8%
|
1,091
-17.3%
|
1,318
+80.3%
|
731
+2.0%
|
717
+7.0%
|
670
|
| Restructuring and impairment |
—
|
3
-94.5%
|
62
+40.3%
|
44
+9054.6%
|
0
+910.4%
|
0
+101.6%
|
-3
-196.4%
|
3
-92.3%
|
41
|
| Operating expenses |
—
|
1,525
|
—
|
—
|
1,190
-15.3%
|
1,405
+76.8%
|
795
|
—
|
—
|
| Operating income |
1,142
+23.1%
|
1,102
+27.1%
|
867
+3.6%
|
836
+5.7%
|
791
+65.6%
|
478
-12.9%
|
548
+2.1%
|
537
+30.7%
|
411
|
| Other income (expense) |
-53
+29.1%
|
-54
+22.7%
|
-70
+47.2%
|
-133
-20.3%
|
-111
+0.2%
|
-111
-260.0%
|
-31
+19.5%
|
-38
+8.8%
|
-42
|
| Pretax income |
1,089
+27.7%
|
1,047
+31.5%
|
796
+13.3%
|
703
+3.3%
|
680
+85.5%
|
367
-29.1%
|
518
+3.8%
|
499
+35.2%
|
369
|
| Income tax |
281
+38.1%
|
262
+42.0%
|
185
+23.5%
|
150
+20.5%
|
124
+50.7%
|
82
-31.8%
|
121
+32.7%
|
91
+41.4%
|
64
|
| Net income |
805
+24.5%
|
782
+27.3%
|
615
+62.5%
|
378
+253.4%
|
107
-56.1%
|
244
-38.6%
|
397
-2.5%
|
408
+34.2%
|
304
|
| Basic EPS |
8.21
+25.1%
|
7.97
+27.7%
|
6.24
+62.9%
|
3.83
+257.9%
|
1.07
-57.2%
|
2.50
-46.4%
|
4.66
-3.1%
|
4.81
+34.0%
|
3.59
|
| Diluted EPS |
8.17
+25.1%
|
7.93
+27.9%
|
6.20
+62.7%
|
3.81
+256.1%
|
1.07
-56.9%
|
2.48
-46.4%
|
4.63
-2.7%
|
4.76
+34.1%
|
3.55
|
| Weighted average shares, basic |
98
-0.5%
|
98
-0.4%
|
99
-0.2%
|
99
-0.9%
|
100
+2.2%
|
98
+14.5%
|
85
+0.5%
|
85
+0.2%
|
85
|
| Weighted average shares, diluted |
98
-0.5%
|
99
-0.4%
|
99
-0.3%
|
99
-0.8%
|
100
+2.0%
|
98
+14.5%
|
86
+0.3%
|
86
+0.2%
|
85
|
| Other measures | |||||||||
| Depreciation and amortization |
491
+1.7%
|
486
+2.2%
|
476
-15.7%
|
565
+2.2%
|
553
-0.0%
|
553
+152.3%
|
219
+11.2%
|
197
-12.7%
|
226
|
| EBITDA |
1,632
+15.8%
|
1,588
+18.3%
|
1,343
-4.2%
|
1,401
+4.3%
|
1,344
+30.4%
|
1,031
+34.3%
|
768
+4.5%
|
734
+15.3%
|
637
|
| Interest coverage |
18.84x
|
18.15x
|
10.04x
|
—
|
—
|
—
|
—
|
—
|
—
|
| Margins | |||||||||
| Gross margin |
44.43%
|
44.25%
|
44.01%
|
43.17%
|
43.66%
|
44.59%
|
43.22%
|
43.55%
|
42.23%
|
| Operating margin |
18.91%
|
18.56%
|
15.87%
|
16.27%
|
17.44%
|
11.31%
|
17.65%
|
17.72%
|
14.77%
|
| Pretax margin |
18.04%
|
17.64%
|
14.58%
|
13.68%
|
15.00%
|
8.69%
|
16.65%
|
16.46%
|
13.26%
|
| Profit margin |
13.33%
|
13.18%
|
11.26%
|
7.36%
|
2.36%
|
5.77%
|
12.79%
|
13.45%
|
10.92%
|
| EBITDA margin |
27.04%
|
26.76%
|
24.60%
|
27.27%
|
29.63%
|
24.41%
|
24.70%
|
24.23%
|
22.89%
|
| Effective tax rate |
25.79%
|
25.04%
|
23.20%
|
21.27%
|
18.24%
|
22.45%
|
23.32%
|
18.22%
|
17.42%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
- Listed as
- STE (NYSE)
- Fiscal year ends
- March 31
- Incorporated in
- Ireland
- Headquarters
- Dublin, Ireland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1757898
- Former names
- STERIS Ltd (until Mar 28, 2019)
Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
- Intuitive Surgical Inc ISRG
- Edwards Lifesciences Corp EW
- Zimmer Biomet Holdings, Inc. ZBH
- Smith & Nephew PLC SNN
- Align Technology Inc ALGN
- MSA Safety Inc MSA
- Establishment Labs Holdings Inc. ESTA
- Cadre Holdings, Inc. CDRE
All 29 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.